Optic nerve hypoplasia
Optic Nerve Hypoplasia (ONH) is a medical condition that is characterized by the underdevelopment of the optic nerve. This condition is congenital, meaning it is present at birth. The optic nerve, which is responsible for transmitting visual signals from the eye to the brain, is smaller than usual in individuals with ONH. This can lead to a range of visual impairments, from mild vision loss to complete blindness.
Causes[edit | edit source]
The exact cause of ONH is unknown. However, it is believed to be associated with certain risk factors during pregnancy, such as young maternal age, alcohol or drug use, and diabetes. Some studies also suggest a possible genetic component.
Symptoms[edit | edit source]
The symptoms of ONH can vary greatly from person to person. Some individuals may have near-normal vision, while others may be completely blind. Additional symptoms can include nystagmus (involuntary eye movement), strabismus (crossed or misaligned eyes), and sensitivity to light.
Diagnosis[edit | edit source]
ONH is typically diagnosed through a comprehensive eye examination. This can include visual acuity testing, a dilated eye exam, and an examination of the optic nerve using ophthalmoscopy or optical coherence tomography (OCT). In some cases, magnetic resonance imaging (MRI) may be used to confirm the diagnosis and rule out other conditions.
Treatment[edit | edit source]
There is currently no cure for ONH. Treatment is focused on managing symptoms and improving the individual's quality of life. This can include low vision aids, mobility training, and educational support. In some cases, hormone replacement therapy may be used to treat associated endocrine disorders.
Prognosis[edit | edit source]
The prognosis for individuals with ONH varies depending on the severity of the condition and the presence of associated disorders. With appropriate support and treatment, many individuals with ONH are able to lead fulfilling lives.
See also[edit | edit source]
| Optic nerve hypoplasia Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
